Trial Profile
A trial to evaluate bone penetration of ceftobiprole in patients following hip replacement surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Community-acquired pneumonia
- Focus Pharmacokinetics
- 17 May 2016 New trial record
- 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases